Ads
related to: pfizer covid vaccine- Schedule A Vaccine
Book A Vaccine Appointment
Today At A Location Near You.
- Questions About Cost?
Visit To Find More Information
On COVID-19 Vaccination Costs.
- Take Eligibility Quiz
Check Your Eligibility For Vaccines
That May Help Protect You.
- Pneumococcal Pneumonia
Visit VaxAssist.com To
See If You Are Eligible.
- Schedule A Vaccine
Search results
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 13 hours agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 5 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 1 day agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Morningstar· 12 hours agoPfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman ...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 13 hours agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 12 hours agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 3 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 3 days agoBut it can be serious or even deadly in babies and older adults. Like rivals Pfizer and GSK — which...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 5 days agoDuring the March quarter, the U...projection. The company also raised its sales outlook for the...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 4 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...